Any day now LONDON (Reuters) - U.S. drugmaker Pfizer has raised its offer for AstraZeneca to 63 billion pounds ($106 billion), it said on Friday, adding that the British drugmaker was reviewing the proposal.
Wrong board, this is the AVANIR board, not the AstraZeneca board. We only have 1 drug with a very small an limited indication.
Nobody will every buy you guys. Today's industry standards go by strict ethics and compliance, which in this case, you guys don't. Off label turds.